Candida Glabrata Esophagitis: new case reports and management

Macêdo, Danielle Patrícia Cerqueira; Silva, Vanessa Karina Alves da; Farias, Aline Mary de Almeida; Melo, Luciana Resende Bandeira de; Wilheim, Ana Botler; Neves, Rejane Pereira

doi:10.1590/s1517-83822008000200015

Cited by 3 publications

(2 citation statements)

References 10 publications

(13 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Хотя Candida albicans (C. albicans) остается наиболее распространенной причиной грибкового эзофагита во многих учреждениях, виды грибов, не относящиеся к С. albicans все чаще ассоциируются с кандидозом пищевода. В частности, растет число сообщений, идентифицирующих Candida glabrata (C. glabrata) в качестве возбудителя кандидозных инфекций слизистых оболочек и системных инфекций [73,74,75]. Показано, что C. glabrata проявляет условно-патогенные свой ства, достигая колонизации через ряд адгезионных белков, имеются сообщения о промежуточной дозозависимой восприимчивости C. glabrata и 20%-ном уровне резистентности к азолам [76,77,78].…”

Section: клиническая картинаunclassified

Management of patients with digestive diseases during the COVID-19 pandemic. Clinical Practice Guidelines by the Russian scientiﬁc medical society of internal medicine (RSMSIM) and the Gastroenterological Scientiﬁc Society of Russia (2nd edition)

Гриневич

Kravchuk

Педь

et al. 2021

jour

View full text Add to dashboard Cite

The presented clinical practice guidelines of the Gastroenterological Scientiﬁc Society of Russia (GSSR), diagnostic, and therapeutic approaches for patients with digestive diseases during the COVID-19 pandemic. The guidelines were approved by the XXIII Congress of the GSSR and the 22nd International Slavonic-Baltic Scientiﬁ c Forum “St. Petersburg - Gastro-2020 ON-LINE” (St. Petersburg, June 11, 2020). The presented clinical practice guidelines of the Russian Scientiﬁc Medical Society of Internal Medicine (RSMSIM) and the Gastroenterological Scientiﬁc Society of Russia (GSSR), diagnostic, and therapeutic approaches for patients with digestive diseases during the COVID-19 pandemic. The recommendations were approved at the XV National Congress of Internal Medicine, XXIII Congress of NOGR on the basis of the 1st edition, adopted at the 22nd International Slavic- Baltic Scientiﬁc Forum “St. Petersburg - Gastro-2020 ON-LINE”.

show abstract

Section: клиническая картинаunclassified

Management of patients with digestive diseases during the COVID-19 pandemic. Clinical Practice Guidelines by the Russian scientiﬁc medical society of internal medicine (RSMSIM) and the Gastroenterological Scientiﬁc Society of Russia (2nd edition)

Гриневич

Kravchuk

Педь

et al. 2021

jour

View full text Add to dashboard Cite

show abstract

“…Although Candida albicans ( C. albicans ) remains the most common cause of fungal esophagitis at many institutions, non- albicans species are increasingly associated with esophageal candidiasis [3]. Specifically, there have been an increasing number of reports identifying Candida glabrata ( C. glabrata ) as the causative agent in candidal mucosal and systemic infections [1, 4–10]. Despite this, publications on C. glabrata make up only a small proportion of publications on medically important fungal infections of the esophagus [11].…”

Section: Introductionmentioning

confidence: 99%

Candida glabrataEsophagitis: Are We Seeing the Emergence of a New Azole-Resistant Pathogen?

Wilson

Delport

Ponich

2014

International Journal of Microbiology

View full text Add to dashboard Cite

Background. Candida glabrata (C. glabrata) has become a recognized pathogen in fungal esophagitis. A proportion of these isolates are azole-resistant which may have treatment implications. Variability in the prevalence of this organism exists in the limited data available. Objective. To determine the incidence of C. glabrata esophagitis in a North American hospital setting and to highlight factors that may predispose patients to this condition. Methods. Patient charts were collected from January 1, 2009 to July 30, 2011. Any charts of patients identified as having esophagitis with a positive fungal culture were reviewed for the species of Candida and the presence of factors that would predispose them to esophageal candidiasis. Results. The prevalence of Candida esophagitis based on culture was 2.2% (37 subjects). C. glabrata was the 2nd most prevalent pathogen identified (24.3% or 9 subjects). Of the C. glabrata cohort, all patients had at least one factor predisposing them to candidiasis. Conclusion. C. glabrata esophagitis makes up a large portion of the candidal esophagitis seen in hospital. C. glabrata infections were associated with at least one risk factor for candidal infection. Given its resistance to azole-based therapy, this may have treatment implications for how candidal esophagitis is approached by the clinician.

show abstract

Candida glabrata is a successful pathogen: An artist manipulating the immune response

Castrejón-Jiménez

Castillo-Cruz

Baltierra‐Uribe

et al. 2022

Microbiological Research

View full text Add to dashboard Cite

Candida Glabrata Esophagitis: new case reports and management

Cited by 3 publications

References 10 publications

Management of patients with digestive diseases during the COVID-19 pandemic. Clinical Practice Guidelines by the Russian scientiﬁc medical society of internal medicine (RSMSIM) and the Gastroenterological Scientiﬁc Society of Russia (2nd edition)

Management of patients with digestive diseases during the COVID-19 pandemic. Clinical Practice Guidelines by the Russian scientiﬁc medical society of internal medicine (RSMSIM) and the Gastroenterological Scientiﬁc Society of Russia (2nd edition)

Candida glabrataEsophagitis: Are We Seeing the Emergence of a New Azole-Resistant Pathogen?

Candida glabrata is a successful pathogen: An artist manipulating the immune response

Contact Info

Product

Resources

About